Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01988350 · ClinicalTrials.gov registry record

Pancreatic Insufficiency Secondary to Tobacco Exposure

A clinical trial, sponsored by Emory University.

Completed
Registry status
202
Enrollment target

NCT01988350: Completed study, sponsored by Emory University.

NCT01988350 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 202 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01988350 has completed, sponsored by Emory University.

COMPLETED
Registry status
202 participants
Enrollment target

Study Summary

Pancreatic insufficiency is a condition in which there is a decrease in the production and release of enzymes made in the pancreas, which causes nutrient malabsorption. There are many chronic diseases that can lead to pancreatic insufficiency. In the early stages of this disease, a patient may not experience any symptoms, and the prevalence of pancreatic insufficiency may be underestimated. Smoking has long been recognized as a cause of disease in many organs in the body. Cigarette smoke causes inflammation and damages tissue, including the pancreas. Studies have shown that smoking is an independent risk factor for pancreatic cancer and chronic pancreatitis. It has also been shown that the more a person smokes, the worse his disease will be. Additionally, there are studies that show that smokers have nutritional deficiencies. There are observational and retrospective studies that suggest that pancreatic insufficiency may also be caused by smoking. However, this has not been established, and the relationship has not been examined in a controlled manner. This study examines the relationship between smoking and pancreatic insufficiency in patients who do not have other pancreatic diseases.

Primary Outcome

The primary outcome is presence or absence of pancreatic insufficiency as determined by fecal elastase-1 measurement

Trial Details

FieldValue
Enrollment Target 202 participants
Start Date 2013-05
Est. Completion 2013-08
Emory University

1,208 total trials

What the finished NCT01988350 record still lists

NCT01988350 is an observational study that tracks outcomes without assigning an intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01988350 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01988350 about?

NCT01988350 is a clinical study titled "Pancreatic Insufficiency Secondary to Tobacco Exposure". Pancreatic insufficiency is a condition in which there is a decrease in the production and release of enzymes made in the pancreas, which causes nutrient malabsorption. There are many chronic diseases that can lead to pancreatic insufficiency. In the early stages of this disease, a patient may not e...

What is the current status of trial NCT01988350?

This trial is currently completed. The enrollment target is 202 participants. The study started on 2013-05. Estimated completion is 2013-08.

Who is sponsoring clinical trial NCT01988350?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05272254 · 202 participants · Phase 2

    Povidone Iodine Efficacy Study

  • NCT05701280 · 202 participants · NA

    Pilot/Pivotal Study of DBS+Rehab After Stroke

  • NCT05932589 · 202 participants

    Neurophysiologic Biomarkers in Rett Syndrome

  • NCT06014931 · 202 participants · NA

    Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01988350, the US trial registry maintained by the National Library of Medicine. NCT01988350 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.